The Self-Injections Market is expected to rise from its initial estimated value of USD 34.94 billion in 2018 to an estimated value of USD 173.75 billion by 2026, registering a CAGR of 22.2% in the forecast period of 2019-2026. This rise in market value can be attributed to rising demand of self-injection devices. Also the Global Self-Injections Market By Type (Devices (Needle-Free, Auto, Pen, Wearable Injectors), Formulations), Dosage Form (Single Dose, Multi-Dose), Therapeutic Application (Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Others), Route of Administration (Skin, Circulatory/Musculoskeletal, Organs, Central Nervous System), End-User (Patient, Physicians, Home Care Settings, Others), Distribution Channel (Hospital Pharmacies, Private Clinics, Chemist, Online Pharmacies), Geography(North America, Europe, Asia-Pacific, Middle East and Africa, South America, Rest of the World) – Industry Trends & Forecast to 2026
Get Free Sample Copy @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-self-injections-market
Key Market Competitors:
Few of the major competitors currently working in the self-injections market are –
Abbvie, Inc. (US), (US) , 3M (US) , BD. (US) ,. Baxter (US), PharmaJet (US), GerresheimerAG (Germany), Pfizer Inc.(US),Terumo Corporation (Japan), Mylan N.V.(US), Bespak(UK), Janssen Global Services, LLC.(US), Insulet Corporation (US), Unilife Corporation(USA), West Pharmaceutical Services, Inc.(US), Ypsomed (Switzerland), Eli lilly and Company (US), Haselmeier AG(Switzerland), Alkermes (Ireland), Credence MedSystems, Inc.(UA), SchottAG(Germany), Ypsomed (Switzerland), Owen Mumford Ltd.(UK), Glide Technology Pvt Ltd. (UK), among other companies.
Competitive Analysis:
Global self-injections market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of self-injections market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Key Developments in the Market:
- In April 2019, Baxter announced the launch of a ready-to-use VANCOMYCIN injection in 0.9% Sodium Chloride in 500 mg, 750 mg and 1 gram presentations.
- In March 2019, Antares Pharma announced receipt of orphan drug designation to evaluate the use of subcutaneous methotrexate for the treatment of ectopic pregnancy that meets predefined criteria for medical management.
Market Drivers
- Rising cases of chronic diseases will act as a driving agent for the market.
advanced and innovated drug comes in the market, this act as a driver to the Self-Injections Market.
Segmentation: Global Self-Injections Market
By Type
- Devices
- Needle-Free
- Auto
- Pen
- Wearable Injectors
By Dosage Form
- Single Dose
- Multi-Dose
By Therapeutic Application
- Autoimmune Diseases
- Hormonal Disorders
- Oncology
- Orphan Diseases
- Pain Management
- Respiratory Therapy
- Others
By Route of Administration
- Skin
- Circulatory/Musculoskeletal
- Organs
- Central Nervous System
By End-user
- Patient
- Physicians
- Home Care Settings
By Distribution Channel
- Hospital Pharmacies
- Private Clinics
- Chemist
- Online Pharmacies
By Geography
- North America
- South America
- Europe
- Asia-Pacific
- Middle East and Africa
Inquiry Before Buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-self-injections-market
Table of Contents:
1. INTRODUCTION
2. MARKET SEGMENTATION
3. MARKET OVERVIEW
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL SELF-INJECTION MARKET, REGULATORY
7. GLOBAL SELF-INJECTION MARKET, REIMBUSEMENT
8. GLOBAL SELF-INJECTION MARKET, BY TYPE
9. GLOBAL SELF-INJECTION MARKET, BY APPLICATION
10. GLOBAL SELF-INJECTION MARKET, BY USAGE PATTERN
11. GLOBAL SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION
12. GLOBAL SELF-INJECTION MARKET, BY END USER
13. GLOBAL SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL
14. GLOBAL SELF-INJECTION MARKET, BY GEOGRAPHY
14.1. OVERVIEW
14.2. NORTH AMERICA
14.3. EUROPE
14.4. APAC
14.5. SOUTH AMERICA
14.6. MEA
15. GLOBAL SELF INJECTION MARKET, COMPANY LANDSCAPE
16. COMPANY PROFILES
16.1. ELCAM MEDICALCOMPANY OVERVIEW
16.2. BESPAK (SUBSIDIARY OF CONSORT MEDICAL COMPANY)
16.3. SANOFI
16.4. SANDOZ INTERNATIONAL GMBH
16.5. SANDOZ INTERNATIONAL GMBH: REVENUE ANALYSIS
16.6. UNILIFE CORPORATION
16.7. WEST PHARMACEUTICAL SERVICES, INC
16.8. PFIZER INC.
16.9. IMPAX LABORATORIES, INC.
16.10. PENJET CORPORATION
16.11. CROSSJECT NEEDLE-FREE INJECTION SYSTEMS
16.12. WILHELM HASELMEIER GMBH & CO. KG
16.13. ANTARES PHARMA
16.14. BECTON, DICKINSON AND COMPANY
16.15. GERRESHEIMER AG
16.16. MYLAN N.V
16.17. NOVO NORDISK
16.18. OWEN MUMFORD LTD
16.19. PHARMAJET
16.20. SHL GROUP
16.21. YPSOMED
Download Detailed TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-self-injections-market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Sopan Gedam
Email: Send Email
Phone: +1-888-387-2818
Address:Office Number 402, Amanora Chambers, Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://databridgemarketresearch.com/reports/global-self-injections-market/